NASDAQ:LMAT - LeMaitre Vascular Stock Price, Price Target & More

$40.48 -0.54 (-1.32 %)

(As of 04/20/2018 04:00 PM ET)

Previous Close$40.48

Today's Range$40.37 - $41.2150

52-Week Range$25.05 - $41.25

Volume82,052 shs

Average Volume131,603 shs

Market Capitalization$785.13 million

P/E Ratio47.07

Dividend Yield0.69%

Beta0.54

About LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Receive LMAT News and Ratings via Email

Sign-up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments

Sub-IndustryN/A

SectorMedical

SymbolNASDAQ:LMAT

CUSIPN/A

Webwww.lemaitre.com

Phone781-221-2266

Debt

Debt-to-Equity RatioN/A

Current Ratio6.09%

Quick Ratio4.50%

Price-To-Earnings

Trailing P/E Ratio47.07

Forward P/E Ratio41.31

P/E Growth2.78

Sales & Book Value

Annual Sales$100.87 million

Price / Sales7.74

Cash Flow$1.0952 per share

Price / Cash36.96

Book Value$5.70 per share

Price / Book7.10

Profitability

EPS (Most Recent Fiscal Year)$0.86

Net Income$17.17 million

Net Margins17.03%

Return on Equity16.93%

Return on Assets14.74%

Miscellaneous

Employees423

Outstanding Shares19,280,000

How to Become a New Pot Stock Millionaire

LeMaitre Vascular (NASDAQ:LMAT) Frequently Asked Questions

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular announced a quarterly dividend on Friday, February 23rd. Investors of record on Thursday, March 22nd will be paid a dividend of $0.07 per share on Thursday, April 5th. This represents a $0.28 annualized dividend and a yield of 0.69%. The ex-dividend date of this dividend is Wednesday, March 21st. This is a boost from LeMaitre Vascular's previous quarterly dividend of $0.06. View LeMaitre Vascular's Dividend History.

How will LeMaitre Vascular's stock buyback program work?

LeMaitre Vascular declared that its board has approved a stock repurchase plan on Friday, July 28th 2017, which allows the company to repurchase $7,500,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 1.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board believes its stock is undervalued.

How were LeMaitre Vascular's earnings last quarter?

LeMaitre Vascular Inc (NASDAQ:LMAT) announced its quarterly earnings data on Wednesday, February, 21st. The medical instruments supplier reported $0.21 EPS for the quarter, beating the Zacks' consensus estimate of $0.20 by $0.01. The medical instruments supplier had revenue of $26.15 million for the quarter, compared to the consensus estimate of $26.23 million. LeMaitre Vascular had a return on equity of 16.93% and a net margin of 17.03%. The company's quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.13 EPS. View LeMaitre Vascular's Earnings History.

What guidance has LeMaitre Vascular issued on next quarter's earnings?

LeMaitre Vascular updated its FY18 earnings guidance on Wednesday, February, 21st. The company provided EPS guidance of $0.96-1.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.88. The company issued revenue guidance of $110.0-111.6 million, compared to the consensus revenue estimate of $111.26 million.LeMaitre Vascular also updated its Q1 guidance to $0.19-0.21 EPS.

What price target have analysts set for LMAT?

5 brokers have issued 12-month price objectives for LeMaitre Vascular's shares. Their forecasts range from $31.00 to $34.00. On average, they anticipate LeMaitre Vascular's share price to reach $32.50 in the next year. View Analyst Ratings for LeMaitre Vascular.

Who are some of LeMaitre Vascular's key competitors?

Some companies that are related to LeMaitre Vascular include Mazor Robotics (MZOR), Irhythm Technologies (IRTC), Intersect ENT (XENT), ATRION (ATRI), Orthofix (OFIX), OraSure Technologies (OSUR), Glaukos (GKOS), Luminex (LMNX), K2M Group (KTWO), MiMedx Group (MDXG), CryoLife (CRY), Cardiovascular Systems (CSII), AtriCure (ATRC), AngioDynamics (ANGO), Cerus (CERS), Anika Therapeutics (ANIK), Tactile Systems Technology (TCMD) and SurModics (SRDX).

Who are LeMaitre Vascular's key executives?

LeMaitre Vascular's management team includes the folowing people:

George W. LeMaitre, Chairman of the Board, Chief Executive Officer (Age 52)
David Brian Roberts, President, Director (Age 53)
Joseph P. Pellegrino Jr., Chief Financial Officer, Director (Age 52)
Trent G. Kamke, Senior Vice President - Operations (Age 46)
Cornelia W. LeMaitre, Vice President - Human Resources (Age 79)
Lawrence J. Jasinski, Independent Director (Age 59)
John J. O'Connor, Independent Director (Age 69)
John A. Roush, Independent Director (Age 52)
Michael H. Thomas, Independent Director (Age 67)

Has LeMaitre Vascular been receiving favorable news coverage?

News articles about LMAT stock have trended somewhat positive recently, Accern reports. The research group rates the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. LeMaitre Vascular earned a coverage optimism score of 0.23 on Accern's scale. They also assigned news stories about the medical instruments supplier an impact score of 44.94 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

How do I buy shares of LeMaitre Vascular?

Shares of LMAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LeMaitre Vascular's stock price today?

One share of LMAT stock can currently be purchased for approximately $40.48.

How big of a company is LeMaitre Vascular?

LeMaitre Vascular has a market capitalization of $785.13 million and generates $100.87 million in revenue each year. The medical instruments supplier earns $17.17 million in net income (profit) each year or $0.86 on an earnings per share basis. LeMaitre Vascular employs 423 workers across the globe.

How can I contact LeMaitre Vascular?

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at 781-221-2266.

MarketBeat Community Rating for LeMaitre Vascular (LMAT)

Community Ranking:		3.0 out of 5 ( )
Outperform Votes:		274 (Vote Outperform)
Underperform Votes:		179 (Vote Underperform)
Total Votes:		453

MarketBeat's community ratings are surveys of what our community members think about LeMaitre Vascular and other stocks. Vote "Outperform" if you believe LMAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LMAT will underperform the S&P 500 over the long term. You may vote once every thirty days.

LeMaitre Vascular (NASDAQ:LMAT) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

5 Wall Street analysts have issued ratings and price targets for LeMaitre Vascular in the last 12 months. Their average twelve-month price target is $32.50, suggesting that the stock has a possible downside of 19.71%. The high price target for LMAT is $34.00 and the low price target for LMAT is $31.00. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Buy
Consensus Rating Score:	2.20	2.20	2.17	2.50
Ratings Breakdown:	0 Sell Rating(s) 4 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 4 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 5 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$32.50	$32.50	$31.50	$30.50
Price Target Upside:	19.71% downside	9.19% downside	0.77% upside	20.70% downside

LeMaitre Vascular (NASDAQ:LMAT) Consensus Price Target History

Price Target History for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
2/23/2018	Canaccord Genuity	Reiterated Rating	Hold	$33.00	Low
10/29/2017	Stifel Nicolaus	Reiterated Rating	Buy		N/A
10/27/2017	Benchmark	Downgrade	Buy -> Hold		N/A
10/27/2017	First Analysis	Downgrade	Overweight -> Equal Weight	$34.00	N/A
6/6/2017	Craig Hallum	Initiated Coverage	Hold	$31.00	Low
2/22/2017	Barrington Research	Downgrade	Outperform -> Market Perform		N/A
9/22/2016	Sidoti	Downgrade	Buy -> Neutral	$23.00	N/A
7/28/2016	Brean Capital	Boost Price Target	Buy	$17.50 -> $20.00	N/A
5/3/2016	Roth Capital	Boost Price Target	Buy	$18.00 -> $18.50	N/A

(Data available from 4/20/2016 forward)

LeMaitre Vascular (NASDAQ:LMAT) Earnings History and Estimates Chart

Earnings by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Earnings Estimates

2018 EPS Consensus Estimate: $0.94

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$0.20	$0.20	$0.20
Q2 2018	2	$0.22	$0.26	$0.24
Q3 2018	2	$0.21	$0.25	$0.23
Q4 2018	2	$0.26	$0.28	$0.27

LeMaitre Vascular (NASDAQ LMAT) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
2/21/2018	Q4 2017	$0.20	$0.21	$26.23 million	$26.15 million	View	Listen
10/26/2017	Q3 2017	$0.20	$0.25	$25.49 million	$24.80 million	View	N/A
7/27/2017	Q2 2017	$0.17	$0.23	$25.42 million	$25.80 million	View	N/A
5/4/2017	Q1 2017	$0.1310	$0.16	$23.48 million	$24.10 million	View	N/A
4/26/2017	Q1 2017	$0.13	$0.16	$23.50 million	$24.14 million	View	N/A
2/21/2017	Q4 2016	$0.15	$0.13	$23.70 million	$23.30 million	View	Listen
10/26/2016	Q3	$0.15	$0.17	$22.20 million	$19.00 million	View	Listen
7/27/2016	Q2	$0.11	$0.14	$21.59 million	$22.40 million	View	Listen
5/2/2016	Q1	$0.10	$0.11	$20.22 million	$20.26 million	View	Listen
2/24/2016	Q415	$0.09	$0.13	$20.10 million	$20.50 million	View	Listen
10/27/2015	Q3	$0.0780	$0.11	$18.78 million	$19.03 million	View	Listen
7/28/2015	Q2	$0.07	$0.10	$18.90 million	$19.90 million	View	Listen
4/28/2015	Q115	$0.05	$0.08	$17.76 million	$18.90 million	View	Listen
2/25/2015	Q314	$0.07	$0.11	$18.90 million	$18.70 million	View	Listen
10/28/2014	Q3	$0.06	$0.05	$17.09 million	$17.50 million	View	Listen
7/29/2014	Q2 2014	$0.05	$0.09	$17.57 million	$18.16 million	View	N/A
4/29/2014	Q1 2014	$0.02	$0.02	$16.99 million	$16.75 million	View	N/A
2/25/2014	Q4	$0.05	$0.05	$16.45 million	$17.92 million	View	Listen
10/29/2013	Q313	$0.04	$0.05	$15.22 million	$15.30 million	View	Listen
7/30/2013	Q2 2013	$0.04	$0.06	$15.42 million	$15.95 million	View	N/A
4/30/2013	Q1 2013	($0.01)	$0.05	$15.00 million	$15.38 million	View	N/A
2/26/2013	Q4 2012	$0.06	$0.03			View	N/A
10/30/2012	Q3 2012	$0.04	$0.04			View	N/A
7/31/2012	Q2 2012	$0.04	$0.05			View	N/A
5/2/2012	Q1 2012	$0.04	$0.02			View	N/A
2/27/2012	Q4 2011	$0.06	$0.03			View	N/A
10/27/2011	Q3 2011	$0.08	$0.06			View	N/A
7/28/2011	Q2 2011	$0.09	$0.06			View	N/A
4/28/2011	Q1 2011	$0.06	$0.05			View	N/A
2/28/2011	Q4 2010		$0.25			View	N/A
10/28/2010	Q3 2010	$0.08	$0.09			View	N/A
7/28/2010	Q2 2010	$0.06	$0.09			View	N/A
4/29/2010	Q1 2010	$0.05	$0.06			View	N/A
3/4/2010	Q4 2009		$0.08			View	N/A
10/28/2009	Q3 2009		$0.08			View	N/A
7/29/2009	Q2 2009	$0.03	$0.06			View	N/A
4/28/2009	Q1 2009	($0.17)	($0.04)			View	N/A
3/3/2009	Q4 2008		$0.03			View	N/A
10/29/2008	Q3 2008	($0.02)	($0.01)			View	N/A
7/29/2008	Q2 2008	($0.04)	($0.04)			View	N/A
4/30/2008	Q1 2008	($0.07)	($0.12)			View	N/A
3/4/2008	Q4 2007	($0.03)	($0.05)			View	N/A

(Earnings results data provided by Zacks Investment Research)

LeMaitre Vascular (NASDAQ:LMAT) Dividend Information

LeMaitre Vascular pays an annual dividend of $0.28 per share, with a dividend yield of 0.69%. LMAT's most recent quarterly dividend payment was Thursday, April 5. LeMaitre Vascular pays out 32.56% of its earnings out as a dividend.

Most Recent Dividend:	4/5/2018
Annual Dividend:	$0.28
Dividend Yield:	0.69%
Payout Ratio:	32.56% (Trailing 12 Months of Earnings) 28.57% (Based on This Year's Estimates) 25.00% (Based on Next Year's Estimates)

Dividend Payments by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/23/2018	quarterly	$0.07	0.78%	3/21/2018	3/22/2018	4/5/2018
10/30/2017	quarterly	$0.0550	0.71%	11/21/2017	11/22/2017	12/7/2017
7/28/2017	quarterly	$0.0550	0.64%	8/21/2017	8/23/2017	9/7/2017
4/28/2017	quarterly	$0.0550	0.74%	5/22/2017	5/24/2017	6/8/2017
2/23/2017	quarterly	$0.0550	1%	3/20/2017	3/22/2017	4/6/2017
10/27/2016	quarterly	$0.0450	0.85%	11/17/2016	11/21/2016	12/5/2016
7/29/2016	quarterly	$0.0450	1.05%	8/18/2016	8/22/2016	9/6/2016
5/4/2016	quarterly	$0.0450	1.12%	5/23/2016	5/25/2016	6/8/2016
2/25/2016	quarterly	$0.0450	1.19%	3/17/2016	3/21/2016	4/4/2016
10/29/2015	quarterly	$0.04	1.11%	11/18/2015	11/20/2015	12/4/2015
7/29/2015	quarterly	$0.04	1.25%	8/18/2015	8/20/2015	9/3/2015
4/29/2015	quarterly	$0.04	1.85%	5/20/2015	5/22/2015	6/5/2015
2/26/2015	quarterly	$0.04	2.03%	3/18/2015	3/20/2015	4/3/2015
10/28/2014	quarterly	$0.0350	1.93%	11/18/2014	11/20/2014	12/4/2014
7/31/2014	quarterly	$0.0350	1.73%	8/19/2014	8/21/2014	9/4/2014
4/30/2014	quarterly	$0.0350	1.71%	5/20/2014	5/22/2014	6/5/2014
2/26/2014	quarterly	$0.0350	1.75%	3/18/2014	3/20/2014	4/3/2014
10/31/2013	quarterly	$0.03	1.49%	11/18/2013	11/20/2013	12/4/2013
7/30/2013	quarterly	$0.03	1.73%	8/19/2013	8/21/2013	9/4/2013
5/2/2013	quarterly	$0.03	1.98%	5/20/2013	5/22/2013	6/5/2013
2/27/2013	quarterly	$0.03	1.92%	3/18/2013	3/20/2013	4/3/2013

(Data available from 1/1/2013 forward)

LeMaitre Vascular (NASDAQ LMAT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 23.70%
Institutional Ownership Percentage: 72.76%

Insider Trading History for LeMaitre Vascular (NASDAQ:LMAT)

Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ LMAT) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/7/2018	George W Lemaitre	Chairman	Sell	30,000	$36.19	$1,085,700.00	3,180,709
3/5/2018	George W Lemaitre	Chairman	Sell	45,000	$34.66	$1,559,700.00	3,225,709
3/2/2018	George W Lemaitre	CEO	Sell	15,000	$34.55	$518,250.00	3,225,709
2/28/2018	George W Lemaitre	CEO	Sell	5,700	$35.56	$202,692.00	3,259,263
2/26/2018	George W Lemaitre	CEO	Sell	42,036	$35.68	$1,499,844.48	3,259,263
11/6/2017	David B Roberts	Insider	Sell	4,123	$32.14	$132,513.22	24,482
8/30/2017	David B Roberts	Insider	Sell	26,683	$36.67	$978,465.61	48,108
8/30/2017	George W Lemaitre	CEO	Sell	15,000	$37.13	$556,950.00	3,325,508
8/29/2017	George W Lemaitre	CEO	Sell	15,000	$36.72	$550,800.00	3,325,508
8/28/2017	George W Lemaitre	CEO	Sell	30,000	$36.43	$1,092,900.00	3,325,508
8/25/2017	George W Lemaitre	Chairman	Sell	40,000	$33.89	$1,355,600.00	3,390,508
8/24/2017	George W Lemaitre	CEO	Sell	15,000	$33.97	$509,550.00	3,390,508
8/23/2017	George W Lemaitre	CEO	Sell	5,000	$33.91	$169,550.00	3,390,508
8/17/2017	Lawrence J Jasinski	Director	Sell	2,030	$34.23	$69,486.90	8,333
8/11/2017	George W Lemaitre	Chairman	Sell	21,300	$32.90	$700,770.00	3,405,508
8/10/2017	George W Lemaitre	CEO	Sell	11,300	$32.79	$370,527.00	3,405,508
8/9/2017	George W Lemaitre	Chairman	Sell	30,000	$33.65	$1,009,500.00	3,436,808
8/8/2017	George W Lemaitre	CEO	Sell	10,000	$34.02	$340,200.00	3,436,808
8/7/2017	George W Lemaitre	CEO	Sell	10,000	$33.62	$336,200.00	3,436,808
8/7/2017	Peter R Gebauer	Insider	Sell	6,224	$33.85	$210,682.40	8,477
8/4/2017	David B Roberts	Insider	Sell	48,317	$33.12	$1,600,259.04	30,105
8/3/2017	George W Lemaitre	Chairman	Sell	58,700	$33.97	$1,994,039.00	3,471,808
8/3/2017	Peter R Gebauer	Insider	Sell	22,067	$34.28	$756,456.76	4,486
8/1/2017	Lawrence J Jasinski	Director	Sell	6,500	$34.47	$224,055.00	12,863
6/1/2017	Michael T Wijas	VP	Sell	2,346	$31.42	$73,711.32	3,584
5/24/2017	Trent G Kamke	Insider	Sell	15,780	$30.28	$477,818.40	31,341
5/18/2017	George W Lemaitre	Chairman	Sell	21,225	$30.11	$639,084.75	3,386,295
5/11/2017	David B Roberts	Insider	Sell	39,531	$30.37	$1,200,556.47	7,414
5/10/2017	George W Lemaitre	Chairman	Sell	63,622	$30.98	$1,971,009.56	3,450,815
5/9/2017	George W Lemaitre	CEO	Sell	34,517	$30.67	$1,058,636.39	3,450,815
5/8/2017	George W Lemaitre	CEO	Sell	9,102	$31.12	$283,254.24	3,450,815
5/4/2017	David B Roberts	Insider	Sell	44,340	$31.14	$1,380,747.60	46,945
5/3/2017	George W Lemaitre	Chairman	Sell	87,342	$32.35	$2,825,513.70	3,484,149
3/10/2017	David B Roberts	Insider	Sell	5,900	$22.44	$132,396.00	46,945
3/1/2017	George W Lemaitre	Chairman	Sell	10,000	$22.36	$223,600.00	3,451,694
2/28/2017	George W Lemaitre	CEO	Sell	3,000	$22.27	$66,810.00	3,451,694
2/27/2017	George W Lemaitre	CEO	Sell	5,000	$22.31	$111,550.00	3,451,694
9/16/2016	David B Roberts	Insider	Sell	6,452	$21.05	$135,814.60	69,793
9/15/2016	David B Roberts	Insider	Sell	33,548	$20.41	$684,714.68	79,793
9/8/2016	George W Lemaitre	Chairman	Sell	30,000	$20.48	$614,400.00	3,395,063
9/7/2016	David B Roberts	Insider	Sell	20,000	$20.07	$401,400.00	119,793
9/2/2016	George W Lemaitre	Chairman	Sell	60,037	$18.30	$1,098,677.10	3,443,098
8/30/2016	Peter R Gebauer	Insider	Sell	3,431	$18.20	$62,444.20	31,283
8/29/2016	Peter R Gebauer	Insider	Sell	26,815	$17.78	$476,770.70	31,283
8/24/2016	David B Roberts	Insider	Sell	10,000	$17.35	$173,500.00	134,793
8/24/2016	George W Lemaitre	CEO	Sell	6,800	$17.49	$118,932.00	3,491,564
8/23/2016	George W Lemaitre	CEO	Sell	19,664	$17.43	$342,743.52	3,491,564
8/22/2016	George W Lemaitre	CEO	Sell	8,927	$17.39	$155,240.53	3,491,564
8/19/2016	Cornelia W Lemaitre	Director	Sell	5,000	$17.15	$85,750.00	188,858
8/18/2016	Cornelia W Lemaitre	Director	Sell	22,500	$17.36	$390,600.00	188,858
8/15/2016	Cornelia W Lemaitre	Director	Sell	22,500	$17.36	$390,600.00	188,858
8/15/2016	George W Lemaitre	Chairman	Sell	15,896	$17.53	$278,656.88	3,512,839
8/9/2016	George W Lemaitre	Chairman	Sell	5,460	$17.41	$95,058.60	3,516,387
8/9/2016	Lawrence J Jasinski	Director	Sell	7,500	$17.60	$132,000.00	12,863
8/5/2016	David B Roberts	Insider	Sell	10,000	$17.63	$176,300.00	140,493
8/4/2016	George W Lemaitre	Chairman	Sell	4,540	$17.65	$80,131.00	3,516,387
7/28/2016	Peter R Gebauer	Insider	Sell	30,000	$16.47	$494,100.00	25,374
6/8/2016	George W Lemaitre	CEO	Sell	19,189	$15.01	$288,026.89	3,521,849
6/7/2016	George W Lemaitre	CEO	Sell	9,100	$15.02	$136,682.00	3,521,849
6/6/2016	George W Lemaitre	CEO	Sell	900	$15.06	$13,554.00	3,521,849
6/6/2016	Peter R Gebauer	Insider	Sell	6,310	$14.96	$94,397.60	53,339
6/3/2016	Lawrence J Jasinski	Director	Sell	4,924	$14.99	$73,810.76	12,787
6/3/2016	Trent G Kamke	Insider	Sell	2,510	$15.00	$37,650.00	15,573
5/25/2016	Lawrence J Jasinski	Director	Sell	6,326	$15.30	$96,787.80	15,642
5/25/2016	Trent G Kamke	Insider	Sell	1,524	$15.25	$23,241.00	18,183
5/23/2016	Trent G Kamke	Insider	Sell	16,465	$15.02	$247,304.30	12,204
5/18/2016	George W Lemaitre	CEO	Sell	2,944	$15.23	$44,837.12	3,522,749
5/17/2016	Trent G Kamke	Insider	Sell	2,400	$15.51	$37,224.00	20,492
5/16/2016	George W Lemaitre	CEO	Sell	1,740	$15.49	$26,952.60	3,522,749
5/13/2016	George W Lemaitre	CEO	Sell	7,451	$15.45	$115,117.95	3,522,749
5/9/2016	George W Lemaitre	CEO	Sell	110,189	$16.17	$1,781,756.13	3,549,133
5/6/2016	David B Roberts	Director	Sell	17,064	$15.89	$271,146.96	162,434
5/5/2016	Trent G Kamke	Insider	Sell	3,327	$16.10	$53,564.70	22,692
4/18/2016	David B Roberts	Director	Sell	1,766	$16.10	$28,432.60	147,136
4/4/2016	David B Roberts	Director	Sell	17,444	$15.99	$278,929.56	107,605
2/25/2016	David B Roberts	Director	Sell	2,690	$15.91	$42,797.90	125,049
1/14/2016	David B. Roberts	Director	Sell	12,867	$15.85	$203,941.95	127,739
1/11/2016	David B Roberts	Director	Sell	27,490	$15.68	$431,043.20	140,606
1/8/2016	David B Roberts	Director	Sell	2,743	$15.51	$42,543.93	168,096
12/9/2015	Joseph P. Pellegrino, Jr.	CFO	Sell	14,348	$16.01	$229,711.48	110,389
12/4/2015	Peter R. Gebauer	insider	Sell	12,816	$15.53	$199,032.48	70,420
12/1/2015	Peter R. Gebauer	insider	Sell	37,184	$15.73	$584,904.32	70,420
11/25/2015	David B. Roberts	Director	Sell	10,000	$15.96	$159,600.00	170,839
11/24/2015	Cornelia W Lemaitre	Director	Sell	41,135	$15.61	$642,117.35	182,595
11/23/2015	George W. Lemaitre	CEO	Sell	65,052	$15.63	$1,016,762.76	3,633,333
11/23/2015	Joseph P. Pellegrino, Jr.	CFO	Sell	45,840	$15.57	$713,728.80	110,389
11/23/2015	Peter R. Gebauer	insider	Sell	11,971	$15.31	$183,276.01	70,420
11/20/2015	David B. Roberts	Director	Sell	10,000	$14.73	$147,300.00	180,839
11/20/2015	Peter R. Gebauer	insider	Sell	19,900	$14.40	$286,560.00	70,420
11/17/2015	George W Lemaitre	CEO	Sell	30,000	$14.15	$424,500.00	3,698,385
11/16/2015	Lawrence J. Jasinski	Director	Sell	7,500	$13.57	$101,775.00	14,113
11/10/2015	George W. Lemaitre	CEO	Sell	57,844	$13.80	$798,247.20	3,728,385
11/9/2015	George W. Lemaitre	CEO	Sell	7,524	$13.70	$103,078.80	3,728,385
11/6/2015	George W. Lemaitre	CEO	Sell	39,000	$13.83	$539,370.00	3,728,385
10/30/2015	George W. Lemaitre	CEO	Sell	16,190	$14.55	$235,564.50	3,786,229
10/28/2015	Peter R. Gebauer	insider	Sell	44,315	$13.97	$619,080.55	70,420
9/25/2015	Peter R. Gebauer	insider	Sell	5,441	$13.91	$75,684.31	70,420
9/18/2015	George W. Lemaitre	CEO	Sell	46,391	$14.37	$666,638.67	3,802,419
9/17/2015	George W. Lemaitre	CEO	Sell	49,559	$13.96	$691,843.64	3,846,869
8/31/2015	Peter R. Gebauer	insider	Sell	10,465	$13.49	$141,172.85	70,420
8/27/2015	George W. Lemaitre	CEO	Sell	28,700	$13.66	$392,042.00	3,888,369
8/26/2015	Peter R. Gebauer	insider	Sell	15,978	$13.53	$216,182.34	70,420
8/20/2015	David B Roberts	Director	Sell	12,000	$13.58	$162,960.00	190,839
8/19/2015	Peter R. Gebauer	insider	Sell	4,022	$14.24	$57,273.28	70,420
8/13/2015	George W Lemaitre	CEO	Sell	33,059	$13.41	$443,321.19
5/19/2015	Peter R Gebauer	Insider	Sell	10,000	$10.12	$101,200.00
5/18/2015	George W Lemaitre	CEO	Sell	20,132	$10.01	$201,521.32
5/11/2015	David B Roberts	Director	Sell	15,000	$10.31	$154,650.00
5/7/2015	George W Lemaitre	CEO	Sell	70,984	$9.72	$689,964.48
5/6/2015	David B Roberts	Director	Sell	11,000	$9.27	$101,970.00
4/29/2015	Peter R Gebauer	Insider	Sell	15,332	$8.99	$137,834.68
4/16/2015	Cornelia W Lemaitre	Director	Sell	17,100	$8.55	$146,205.00
4/14/2015	Cornelia W Lemaitre	Director	Sell	6,707	$8.42	$56,472.94
3/31/2015	Cornelia W Lemaitre	Director	Sell	819	$8.37	$6,855.03
3/30/2015	Cornelia W Lemaitre	Director	Sell	31	$8.36	$259.16
3/25/2015	Cornelia W Lemaitre	Director	Sell	3,678	$8.33	$30,637.74
3/24/2015	Cornelia W Lemaitre	Director	Sell	3,373	$8.33	$28,097.09
3/23/2015	Cornelia W Lemaitre	Director	Sell	26,026	$8.21	$213,673.46
3/18/2015	Cornelia W Lemaitre	Director	Sell	5,601	$8.03	$44,976.03
3/10/2015	Peter R Gebauer	Insider	Sell	10,000	$8.15	$81,500.00
3/9/2015	Peter R Gebauer	Insider	Sell	7,200	$8.15	$58,680.00
3/6/2015	Cornelia W Lemaitre	Director	Sell	6,065	$8.20	$49,733.00
3/3/2015	David B Roberts	Director	Sell	12,000	$7.65	$91,800.00
1/29/2015	Peter R Gebauer	Insider	Sell	16,919	$7.91	$133,829.29
1/26/2015	George W Lemaitre	CEO	Sell	3,486	$7.85	$27,365.10
1/26/2015	Peter R Gebauer	Insider	Sell	1,800	$7.90	$14,220.00
1/5/2015	George W Lemaitre	CEO	Sell	18,447	$7.74	$142,779.78
1/2/2015	David B Roberts	Director	Sell	7,000	$7.31	$51,170.00
12/30/2014	George W Lemaitre	CEO	Sell	18,067	$7.58	$136,947.86
12/29/2014	George W Lemaitre	CEO	Sell	5,058	$7.59	$38,390.22
12/26/2014	George W Lemaitre	CEO	Sell	6,693	$7.53	$50,398.29
12/24/2014	George W Lemaitre	CEO	Sell	2,900	$7.60	$22,040.00
12/10/2014	George W Lemaitre	CEO	Sell	1,117	$7.40	$8,265.80
12/9/2014	David B Roberts	Director	Sell	3,000	$7.36	$22,080.00
12/9/2014	George W Lemaitre	CEO	Sell	1,794	$7.40	$13,275.60
11/28/2014	George W Lemaitre	CEO	Sell	42,641	$7.40	$315,543.40
11/25/2014	George W Lemaitre	CEO	Sell	613	$7.30	$4,474.90
11/13/2014	Trent G Kamke	Insider	Sell	1,100	$7.15	$7,865.00
11/5/2014	George W Lemaitre	CEO	Sell	28,286	$7.07	$199,982.02
10/31/2014	David B Roberts	President	Sell	3,500	$7.03	$24,605.00
10/31/2014	George W Lemaitre	CEO	Sell	23,758	$7.14	$169,632.12
9/8/2014	George W Lemaitre	CEO	Sell	29,966	$7.10	$212,758.60
9/4/2014	Lawrence J Jasinski	Director	Sell	3,750	$7.14	$26,775.00
6/25/2014	Cornelia W Lemaitre	Director	Sell	4,700	$8.32	$39,104.00
5/7/2014	David Roberts	President	Sell	3,000	$7.95	$23,850.00	206,710
3/7/2014	Russell Hays	Director	Sell	15,000	$8.07	$121,050.00
3/6/2014	Cornelia Lemaitre	Director	Sell	6,950	$8.15	$56,642.50	174,581
3/6/2014	Trent Kamke	Insider	Sell	1,278	$8.18	$10,454.04	16,141
3/4/2014	Cornelia Lemaitre	Director	Sell	12,845	$8.29	$106,485.05	174,581
1/23/2014	Cornelia Lemaitre	Director	Sell	3,900	$8.24	$32,136.00	174,581
11/1/2013	David B Roberts	Director	Sell	2,000	$7.96	$15,920.00
10/31/2013	Cornelia W Lemaitre	Director	Sell	20,000	$7.88	$157,600.00
10/25/2013	Cornelia W Lemaitre	Director	Sell	20,000	$7.38	$147,600.00
9/5/2013	Joseph P Pellegrino Jr	CFO	Sell	25,000	$6.86	$171,500.00
9/3/2013	David B Roberts	Director	Sell	6,500	$6.90	$44,850.00
8/14/2013	Cornelia W Lemaitre	Director	Sell	7,500	$7.00	$52,500.00
8/12/2013	Trent G Kamke	Insider	Sell	2,000	$6.90	$13,800.00
8/8/2013	Trent G Kamke	Insider	Sell	2,000	$6.83	$13,660.00
8/2/2013	Russell D Hays	Director	Sell	15,000	$6.78	$101,700.00
7/30/2013	David B Roberts	Director	Sell	12,403	$6.85	$84,960.55
7/29/2013	Cornelia W Lemaitre	Director	Sell	2,500	$7.00	$17,500.00
7/26/2013	David B Roberts	Director	Sell	9,100	$6.77	$61,607.00
6/24/2013	David B Roberts	Director	Sell	2,100	$6.75	$14,175.00
6/5/2013	Robert V Linden	VP	Sell	9,383	$6.45	$60,520.35
5/30/2013	Cornelia W Lemaitre	Director	Sell	10,000	$6.50	$65,000.00
11/27/2012	Cornelia W Lemaitre	Director	Sell	2,699	$6.25	$16,868.75
8/10/2012	George D Lemaitre	Director	Sell	5,862	$6.45	$37,809.90

(Data available from 1/1/2013 forward)

LeMaitre Vascular (NASDAQ LMAT) News Headlines

Source:

Date	Headline
	LeMaitre Vascular (LMAT) Stock Rating Lowered by Zacks Investment Research www.americanbankingnews.com - April 20 at 10:45 AM
	LeMaitre Vascular Inc (LMAT) Receives Average Rating of "Buy" from Brokerages www.americanbankingnews.com - April 20 at 1:43 AM
	LeMaitre Vascular Will Announce First Quarter 2018 Earnings Results on April 25, 2018 finance.yahoo.com - April 18 at 4:43 PM
	LeMaitre Vascular (LMAT) Cut to "Buy" at BidaskClub www.americanbankingnews.com - April 16 at 9:16 AM
	LeMaitre Vascular (LMAT) Raised to "Buy" at Zacks Investment Research www.americanbankingnews.com - April 14 at 8:01 PM
	LeMaitre Vascular, Inc. (LMAT) Sees Hammer Chart Pattern: Time to Buy? finance.yahoo.com - April 11 at 10:07 AM
	LeMaitre Vascular Inc (LMAT) Expected to Post Quarterly Sales of $26.41 Million www.americanbankingnews.com - April 8 at 2:10 AM
	Zacks: Brokerages Expect LeMaitre Vascular Inc (LMAT) to Announce $0.20 Earnings Per Share www.americanbankingnews.com - April 6 at 7:16 PM
	Lemaitre Vascular (LMAT) Sells General Surgery Product Lines for $7.4M www.streetinsider.com - April 6 at 9:55 AM
	LeMaitre Vascular Divests General Surgery Product Lines finance.yahoo.com - April 6 at 9:55 AM
	LeMaitre Vascular (LMAT) Rating Increased to Buy at ValuEngine www.americanbankingnews.com - April 5 at 1:11 PM
	Head-To-Head Survey: Cryolife (CRY) vs. LeMaitre Vascular (LMAT) www.americanbankingnews.com - April 5 at 3:23 AM
	LeMaitre Vascular (LMAT) Raised to Buy at Zacks Investment Research www.americanbankingnews.com - April 3 at 10:58 PM
	BidaskClub Upgrades LeMaitre Vascular (LMAT) to Strong-Buy www.americanbankingnews.com - April 3 at 11:00 AM
	LeMaitre Vascular (LMAT) Lowered to "Hold" at Zacks Investment Research www.americanbankingnews.com - March 31 at 4:56 PM
	Zacks Investment Research Downgrades LeMaitre Vascular (LMAT) to Hold www.americanbankingnews.com - March 30 at 11:10 PM
	LeMaitre Vascular (LMAT) Raised to "Sell" at BidaskClub www.americanbankingnews.com - March 28 at 12:34 AM
	LeMaitre Vascular Inc (LMAT) Given Consensus Rating of "Hold" by Brokerages www.americanbankingnews.com - March 26 at 1:34 AM
	LeMaitre Vascular (LMAT) Stock Rating Upgraded by BidaskClub www.americanbankingnews.com - March 25 at 9:49 AM
	Zacks Investment Research Upgrades LeMaitre Vascular (LMAT) to "Buy" www.americanbankingnews.com - March 24 at 7:20 PM
	LeMaitre Vascular (LMAT) Cut to "Hold" at BidaskClub www.americanbankingnews.com - March 24 at 4:30 PM
	LeMaitre Vascular Inc (LMAT) Expected to Post Earnings of $0.20 Per Share www.americanbankingnews.com - March 20 at 9:08 PM
	Edited Transcript of LMAT earnings conference call or presentation 21-Feb-18 10:00pm GMT finance.yahoo.com - March 20 at 4:20 PM
	LeMaitre Vascular Inc Forecasted to Earn Q4 2018 Earnings of $0.28 Per Share (LMAT) www.americanbankingnews.com - March 12 at 6:34 AM
	LeMaitre Vascular (LMAT) Upgraded at BidaskClub www.americanbankingnews.com - March 10 at 5:28 PM
	Insider Selling: LeMaitre Vascular Inc (LMAT) Chairman Sells 30,000 Shares of Stock www.americanbankingnews.com - March 8 at 6:29 PM
	LeMaitre Vascular Inc (LMAT) Shares Sold by Ranger Investment Management L.P. www.americanbankingnews.com - March 6 at 2:11 PM
	LeMaitre Vascular Inc (LMAT) Shares Sold by AWM Investment Company Inc. www.americanbankingnews.com - March 6 at 4:44 AM
	Insider Selling: LeMaitre Vascular Inc (LMAT) CEO Sells 15,000 Shares of Stock www.americanbankingnews.com - March 5 at 9:30 PM
	LeMaitre Vascular Inc (LMAT) Chairman Sells $1,559,700.00 in Stock www.americanbankingnews.com - March 5 at 9:11 PM
	Zacks: Analysts Expect LeMaitre Vascular Inc (LMAT) Will Post Quarterly Sales of $26.41 Million www.americanbankingnews.com - March 5 at 3:44 AM
	Zacks: Analysts Expect LeMaitre Vascular Inc (LMAT) Will Post Earnings of $0.20 Per Share www.americanbankingnews.com - March 3 at 5:24 PM
	LeMaitre Vascular Inc (LMAT) Given Average Recommendation of "Hold" by Analysts www.americanbankingnews.com - March 1 at 1:26 AM
	LeMaitre Vascular Inc (LMAT) CEO Sells $202,692.00 in Stock www.americanbankingnews.com - March 1 at 12:38 AM
	Insider Selling: LeMaitre Vascular Inc (LMAT) CEO Sells 42,036 Shares of Stock www.americanbankingnews.com - March 1 at 12:20 AM
	LeMaitre Vascular to Present at Upcoming Investor Conferences finance.yahoo.com - February 28 at 9:25 AM
	Comerica Bank Raises Holdings in LeMaitre Vascular Inc (LMAT) www.americanbankingnews.com - February 27 at 6:00 AM
	Q1 2018 EPS Estimates for LeMaitre Vascular Inc Lifted by Barrington Research (LMAT) www.americanbankingnews.com - February 26 at 2:26 AM
	LeMaitre Vascular's (LMAT) "Hold" Rating Reaffirmed at Canaccord Genuity www.americanbankingnews.com - February 24 at 7:10 AM
	LeMaitre Vascular Inc (LMAT) Declares Quarterly Dividend of $0.07 www.americanbankingnews.com - February 23 at 5:04 PM
	LeMaitre Vascular (LMAT) Issues Earnings Results www.americanbankingnews.com - February 22 at 10:50 AM
	LeMaitre Vascular (LMAT) Releases FY18 Earnings Guidance www.americanbankingnews.com - February 21 at 6:44 PM
	LeMaitre Vascular (LMAT) Releases Q1 Earnings Guidance www.americanbankingnews.com - February 21 at 6:44 PM
	LeMaitre Q4 2017 Record Sales $26.2mm (+12%), Record Op. Income $6.3mm (+62%) finance.yahoo.com - February 21 at 4:41 PM
	LeMaitre beats 4Q profit forecasts finance.yahoo.com - February 21 at 4:41 PM
	LeMaitre Vascular Will Announce Fourth Quarter 2017 Earnings Results on February 21, 2018 finance.yahoo.com - February 9 at 9:12 AM
	LeMaitre Vascular Inc (LMAT) Given Consensus Recommendation of "Hold" by Analysts www.americanbankingnews.com - February 4 at 1:32 AM
	LeMaitre Vascular (LMAT) Raised to Hold at BidaskClub www.americanbankingnews.com - January 31 at 10:54 PM
	LeMaitre Vascular Inc (LMAT) Expected to Post Quarterly Sales of $26.29 Million www.americanbankingnews.com - January 31 at 9:30 AM
	Financial Analysis: Reshape Lifesciences (RSLS) & LeMaitre Vascular (LMAT) www.americanbankingnews.com - January 19 at 5:32 PM

LeMaitre Vascular (NASDAQ:LMAT) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

LeMaitre Vascular (NASDAQ:LMAT) Income Statement, Balance Sheet and Cash Flow Statement

LeMaitre Vascular (NASDAQ LMAT) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff